This means that passive immunization with tau antibodies is actually a feasible therapeutic goal and that the CSF level of p-tau262/356 or with the microtubule binding area (MTBD) can function a valuable biomarker of tau pathology to watch tau therapeutics in medical trials.Likewise, in co-cultures of rat Major cells grown inside a salt Answer that